Immunotherapy in Special Patient Populations and Future Directions
Download this slideset from a live CCO symposium for expert perspective on optimal use of immunotherapy in various patient populations, including those with CNS metastases or poor performance status, along with highlights of emerging data on immunotherapy combination regimens in clinical trials.
Consultant Medical Oncologist Beaumont Hospital/RCSI University of Health Sciences Dublin, Ireland Adjunct Professor of Oncology Sidney Kimmel Comprehensive Johns Hopkins University Baltimore, Maryland
Provided by Clinical Care Options, LLC
Supported by an educational grant from
Regeneron Pharmaceuticals, Inc.
Select date of attendance
Accept Terms and Conditions
Leaving The Site